Equities analysts forecast that Castlight Health, inc. (NYSE:CSLT) will post sales of $30.96 million for the current quarter, according to Zacks. Three analysts have provided estimates for Castlight Health, inc.’s earnings, with the lowest sales estimate coming in at $30.90 million and the highest estimate coming in at $31.05 million. Castlight Health, inc. reported sales of $23.59 million in the same quarter last year, which would suggest a positive year over year growth rate of 31.2%. The company is expected to issue its next quarterly earnings report after the market closes on Wednesday, August 2nd.

According to Zacks, analysts expect that Castlight Health, inc. will report full year sales of $30.96 million for the current fiscal year, with estimates ranging from $132.30 million to $134.27 million. For the next year, analysts forecast that the firm will report sales of $167.32 million per share, with estimates ranging from $155.10 million to $177.32 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that follow Castlight Health, inc..

Castlight Health, inc. (NYSE:CSLT) last posted its quarterly earnings data on Wednesday, April 26th. The software maker reported ($0.05) earnings per share for the quarter, meeting the consensus estimate of ($0.05). The firm had revenue of $27.70 million during the quarter, compared to analysts’ expectations of $28.40 million. Castlight Health, inc. had a negative net margin of 48.72% and a negative return on equity of 43.23%. The company’s quarterly revenue was up 22.0% compared to the same quarter last year. During the same quarter last year, the company posted ($0.13) EPS.

A number of research analysts have recently commented on CSLT shares. Zacks Investment Research cut shares of Castlight Health, inc. from a “buy” rating to a “hold” rating in a report on Monday, April 10th. Dougherty & Co started coverage on shares of Castlight Health, inc. in a report on Wednesday, May 10th. They issued a “buy” rating and a $5.50 target price for the company. Morgan Stanley cut shares of Castlight Health, inc. from an “equal weight” rating to an “underweight” rating and dropped their target price for the stock from $4.00 to $3.75 in a report on Friday, May 12th. ValuEngine cut shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a report on Friday, May 19th. Finally, Chardan Capital started coverage on shares of Castlight Health, inc. in a report on Tuesday, June 6th. They issued a “buy” rating and a $4.50 target price for the company. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $4.44.

TRADEMARK VIOLATION WARNING: “Castlight Health, inc. (NYSE:CSLT) Expected to Announce Quarterly Sales of $30.96 Million” was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/07/16/castlight-health-inc-nysecslt-expected-to-announce-quarterly-sales-of-30-96-million.html.

Castlight Health, inc. (NYSE:CSLT) traded up 2.25% during midday trading on Friday, reaching $4.55. 387,134 shares of the company’s stock traded hands. Castlight Health, inc. has a 52-week low of $3.05 and a 52-week high of $5.50. The stock has a 50-day moving average of $3.88 and a 200 day moving average of $3.83. The company’s market cap is $593.84 million.

In related news, insider Giovanni M. Colella sold 11,456 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $3.75, for a total value of $42,960.00. Following the completion of the transaction, the insider now owns 88,094 shares in the company, valued at approximately $330,352.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Priya Jain sold 7,858 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $3.65, for a total transaction of $28,681.70. Following the completion of the transaction, the chief accounting officer now owns 20,000 shares of the company’s stock, valued at approximately $73,000. The disclosure for this sale can be found here. In the last quarter, insiders sold 37,051 shares of company stock valued at $140,343. 37.43% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of CSLT. Oxford Asset Management acquired a new position in shares of Castlight Health, inc. during the first quarter worth about $102,000. Stifel Financial Corp raised its position in shares of Castlight Health, inc. by 4.3% in the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock worth $133,000 after buying an additional 1,500 shares during the period. FNY Partners Fund LP acquired a new position in shares of Castlight Health, inc. during the first quarter worth about $164,000. Edge Wealth Management LLC acquired a new position in shares of Castlight Health, inc. during the first quarter worth about $172,000. Finally, Cowen Prime Services LLC acquired a new position in shares of Castlight Health, inc. during the first quarter worth about $183,000. Institutional investors and hedge funds own 39.35% of the company’s stock.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Get a free copy of the Zacks research report on Castlight Health, inc. (CSLT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.